Transforming growth factor‐β in cutaneous melanoma
- 1 April 2008
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 21 (2), 123-132
- https://doi.org/10.1111/j.1755-148x.2008.00450.x
Abstract
Transforming growth factor-beta (TGF-beta) plays a complex role during carcinogenesis. It may either act as a tumor suppressor through its broad antiproliferative potential or as a tumor promoter either via direct effects on tumor cell aggressiveness or indirectly by modulating stromal responses, angiogenesis and immune surveillance. Increased production of TGF-beta by cancer cells is often associated with tumor grade. Melanoma cells largely escape cell cycle arrest normally induced by TGF-beta in normal melanocytes, yet produce active TGF-beta and are capable of efficient transcriptional responses to the growth factor. In this review, we summarize the current knowledge about the role played by TGF-beta in melanoma progression and hypothesize about the appropriateness of targeting TGF-beta signaling for therapeutic intervention.Keywords
This publication has 93 references indexed in Scilit:
- Rewired ERK-JNK Signaling Pathways in MelanomaCancer Cell, 2007
- Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and InvasivenessPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressivenessNature Medicine, 2006
- Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor KinaseIn vivoClinical Cancer Research, 2006
- Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase InhibitorCancer Research, 2006
- Bone Sialoprotein Mediates the Tumor Cell–Targeted Prometastatic Activity of Transforming Growth Factor β in a Mouse Model of Breast CancerCancer Research, 2006
- Targeted tumor therapy with the TGF-β2 antisense compound AP 12009Cytokine & Growth Factor Reviews, 2006
- New insights into TGF-β–Smad signallingTrends in Biochemical Sciences, 2004
- Smad-dependent and Smad-independent pathways in TGF-β family signallingNature, 2003
- TGF-β signaling: positive and negative effects on tumorigenesisCurrent Opinion in Genetics & Development, 2002